Novo Nordisk and Nvidia Just Partnered on AI. Is the Stock a Buy? | The Motley Fool

Retrieved on: 2024-03-26 21:49:25

Tags for this article:

Novo Nordisk

Peptide hormones

Pharmaceutical industry

Novo Holdings A/S

Click the tags to see associated articles and topics

Novo Nordisk and Nvidia Just Partnered on AI. Is the Stock a Buy? | The Motley Fool. View article details on HISWAI: https://www.fool.com/investing/2024/03/26/novo-nordisk-and-nvidia-just-partnered-on-ai-is-th/

Summary

Novo Nordisk, a giant in peptide therapeutics like semaglutide, has partnered with Nvidia to build a supercomputing center for innovative drug R&D, potentially harnessing AI and quantum computing. This collaboration could lead to breakthroughs in the pharmaceutical industry.

Article found on: www.fool.com

View Original Article